Comparative Effectiveness of Readmission Reduction Interventions for Individuals with Sepsis or Pneumonia

Completed · Not applicable

Conditions studied: Sepsis, Pneumonia, Lower Resp Tract Infection, Covid19

In brief

An adaptive platform trial to compare effectiveness of different care models to prevent readmissions for patients hospitalized with sepsis or lower respiratory tract infection. The primary outcome is number of days spent at home within 90 days after hospital discharge.

Key facts

Study ID: NCT04829188
Run by: University of Pittsburgh
People needed: 1288
Starts: 2021-03-30
Expected to finish: 2024-12-15
Last updated by the study team: 2025-01-16

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

UPMC Health Plan members
Medicare Fee-for-Service enrollees
Age 21+ -Hospitalized with a primary diagnosis of sepsis or lower respiratory tract infection, --
Discharged to home, independent living facility, or skilled nursing facility
Readmission risk is moderate or high

You may not qualify if…

Admitted from hospice;
Discharged to hospice, inpatient rehabilitation, or a long term acute care facility;
Known to be pregnant;
Current enrollment in another remote patient monitoring program;
Failure of the Callahan 6 item cognitive screen and do not have a proxy to consent;
No access to a technological device required to participate in remote patient monitoring program;
Current enrollment in UPMC Advanced Illness Care program;
Severe, persistent cognitive impairment;
No documented PCP;
PCP disapproves of the patient being enrolled in remote patient monitoring;
Discharged from hospital to skilled nursing facility and stay at the skilled nursing facility for greater than 28 days

Where it is running

UPMC Presbyterian — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.